Brother Enterprises (002562)2024-07-12 10:57Financial Performance - The estimated net profit attributable to shareholders for the first half of 2024 is projected to be between 14 million and 19 million yuan, representing a decrease of 57.73% to 68.85% compared to the same period last year, which was 44.94 million yuan [2]. - The net profit after deducting non-recurring gains and losses is expected to be between 10 million and 15 million yuan, an increase of 360.12% to 490.18% compared to a loss of 3.84 million yuan in the same period last year [2]. - Basic earnings per share are projected to be between 0.013 yuan and 0.018 yuan, compared to 0.042 yuan in the previous year [2]. - In Q2 2024, the net profit attributable to shareholders is expected to be between 39.20 million and 44.20 million yuan, an increase of 255.55% to 275.38% compared to Q1 2024 [5]. - The net profit after deducting non-recurring gains and losses for Q2 2024 is expected to be between 35.80 million and 40.80 million yuan, an increase of 238.76% to 258.15% compared to Q1 2024 [5]. Factors Influencing Performance - The increase in net profit is attributed to rising prices and sales volume of certain vitamin products, along with a decrease in inventory and product costs [4]. - The company received a significant distribution of 41.31 million yuan from Jiaxing Zhonghua Chemical Co., Ltd. in the previous year, which impacted the year-on-year comparison [4]. Financial Reporting - The preliminary financial data provided in the earnings forecast has not been audited by external auditors [3]. - The detailed financial data will be disclosed in the company's 2024 semi-annual report [6]. Investor Advisory - Investors are advised to invest rationally and pay attention to risks [6].